Adoption of the new antimalarial drug policy in Tanzania – a cross‐sectional study in the community

Objective  To assess the diffusion of the change of first line antimalarial drug from chloroquine (CQ) to sulphadoxine/pyrimethamine (SP) at household level in a rural district of Tanzania less than a year after the policy implementation.

[1]  M. Leshabari,et al.  Availability and Usage of Drugs at Household Level i Tanzania: Case Study in Kinondoni District, Dar es Salaam , 2005 .

[2]  Imelda Bates,et al.  Malaria misdiagnosis: effects on the poor and vulnerable , 2004, The Lancet.

[3]  D. Durrheim,et al.  The process of changing national malaria treatment policy: lessons from country-level studies. , 2004, Health policy and planning.

[4]  G. Tomson,et al.  Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  M. Galinski,et al.  WHO, the Global Fund, and medical malpractice in malaria treatment , 2004, The Lancet.

[6]  Robert E Black,et al.  Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. , 2003, The Lancet. Infectious diseases.

[7]  R. Snow,et al.  Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa. , 2003, Trends in parasitology.

[8]  D. Berwick.  Disseminating innovations in health care. , 2003, JAMA.

[9]  G. Tomson,et al.  Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania , 2003, Journal of clinical pharmacy and therapeutics.

[10]  L. Gustafsson,et al.  High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  McCombie Sc,et al.  Self-treatment for malaria: the evidence and methodological issues. , 2002 .

[12]  M. Kamya,et al.  Increasing antimalarial drug resistance in Uganda and revision of the national drug policy , 2002, Tropical medicine & international health : TM & IH.

[13]  L. Gustafsson,et al.  Case management of malaria in under‐fives at primary health care facilities in a Tanzanian district , 2002, Tropical medicine & international health : TM & IH.

[14]  S. P. Kachur,et al.  Insecticide‐treated bednet use, anaemia, and malaria parasitaemia in Blantyre District, Malawi , 2002, Tropical medicine & international health : TM & IH.

[15]  I. Bygbjerg,et al.  Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy , 2001, Tropical medicine & international health : TM & IH.

[16]  F. Nuwaha,et al.  The challenge of chloroquine-resistant malaria in sub-Saharan Africa. , 2001, Health policy and planning.

[17]  R. Snow,et al.  Using evidence to change antimalarial drug policy in Kenya , 2000, Tropical medicine & international health : TM & IH.

[18]  R. Snow,et al.  Averting a malaria disaster , 1999, The Lancet.

[19]  G. Tomson,et al.  A Household Survey of Source, Availability, and use of Antimalarials in a Rural Area of Tanzania , 1999 .

[20]  Judith Green,et al.  Commentary: grounded theory and the constant comparative method. , 1998, BMJ.

[21]  S. McCombie.  Treatment seeking for malaria: a review of recent research. , 1996, Social science & medicine.

[22]  W. Wernsdorfer,et al.  High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  S. Foster,et al.  Treatment of malaria outside the formal health services. , 1995, The Journal of tropical medicine and hygiene.

[24]  M. Halloran,et al.  Malaria: living with drug resistance. , 1993, Parasitology today.

[25]  L. Gustafsson,et al.  Handbook Of Drugs For Tropical Parasitic Infections , 1987 .

[26]  L. Rombo,et al.  Sulfadoxine Assay Using Capillary Blood Samples Dried on Filter Paper—Suitable for Monitoring of Blood Concentrations in the Field , 1987, Therapeutic drug monitoring.

[27]  S. McCombie,et al.  Self-treatment for malaria: the evidence and methodological issues. , 2002, Health policy and planning.

[28]  P. Brasseur,et al.  Combination therapy for malaria: the way forward? , 2002, Drugs.

[29]  J. Breman,et al.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. , 2001, The American journal of tropical medicine and hygiene.

[30]  A. Hardon,et al.  Applied Health Research. Anthropology of Health and Health Care , 2001 .

[31]  P. Bloland,et al.  Combination therapy for malaria in Africa: hype or hope? , 2000, Bulletin of the World Health Organization.

[32]  D. Savigny,et al.  Implementation of a new anti-malaria treatment policy in Tanzania: the rationale for change and guide to the process of policy implementation , 2000 .

[33]  P. Bloland,et al.  Making malaria-treatment policy in the face of drug resistance. , 1999, Annals of tropical medicine and parasitology.

[34]  J. Killewo,et al.  Self-medication with antimalarial drugs in Dar es Salaam, Tanzania. , 1995, Tropical and geographical medicine.

[35]  R. Agwanda,et al.  Oral rehydration therapy and social marketing in rural Kenya. , 1990, Social science & medicine.

[36]  L. Kaye.  Department of Sociology , 1973 .